Correlation of oral Vitamin D administration with the severity of psoriasis and the presence of metabolic syndrome

Abstract

To improve the management of psoriasis, we have started from the hypothesis that normalization of Vitamin D serum reduces the severity of psoriasis and positively influences the diagnostic criteria of metabolic syndrome. Experimental part. The objective of the prospective study was to evaluate the impact of oral Vitamin D on psoriazis and metabolic syndrome in a group of 184 patients diagnosed with psoriazis and metabolic syndrome, between 2010-2017. In all patients included in the study, we evaluated family history, personal medical history, the living and working conditions, the history of psoriatic disease (control group only), clinical data (waist circumference), height (cm), body mass index, blood pressure (mmHg)) and laboratory examinations. Regarding the severity of psoriasis, in all 141 patients treated with Vitamin D, a significant improvement was seen after 12 months of treatment. We bring a new approach to the treatment of psoriasis with Vitamin D.